概括
大肠杆菌的阿斯巴拉金酶消耗瘤糖氨酸,抑制淋巴细胞瘤的生长. 这种效应被甘氨酸或氨酸逆转,突出显示了甘氨酸在氨酸合成和瘤进展中的作用.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 小鼠中的6C3HED淋巴肉瘤对大肠杆菌氨酸酶敏感.
- 阿斯巴拉金纳斯治疗导致瘤内的细胞甘氨酸度下降.
- 抗阿斯巴拉金酶的瘤不会表现出这种糖氨酸枯竭.
研究的目的:
- 为了研究大肠杆菌阿斯巴拉金酶对6C3HED淋巴瘤中细胞甘氨酸水平的影响.
- 为了确定甘氨酸枯竭在阿斯巴拉金酶诱导的瘤抑制中的作用.
- 为了探索逆转阿斯巴拉金酶的作用与氨基酸管理的潜力.
主要方法:
- 向携带6C3HED淋巴瘤的C3H/HE小鼠注射大肠杆菌菜酶或几内亚猪血清.
- 在瘤组织中测量细胞甘氨酸度.
- 通过腹腔内氨基酸注射抑制和逆转淋巴肉瘤影响的评估.
主要成果:
- 阿斯帕拉金纳斯的使用显著降低了敏感淋巴瘤中的甘氨酸度.
- 在抗阿斯巴拉金酶的瘤中没有观察到甘氨酸的显著下降.
- 内注射的阿斯巴拉金或甘氨酸逆转了阿斯巴拉金酶对淋巴瘤的抑制作用.
- 其他氨基酸,包括lysine,threonine,serine和酸,没有逆转抑制.
结论:
- 细胞甘氨酸的耗尽是阿斯巴拉金酶抑制6C3HED淋巴瘤生长的关键机制.
- 甘氨酸在氨酸合成中的作用可能对瘤细胞活力至关重要,使其耗尽成为治疗有效性的重要因素.
- 阿斯巴拉金和甘氨酸的特异性逆转表明,有针对性的代谢途径参与了阿斯巴拉金酶的作用.
相关概念视频
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...